Le Morvan V - Search Results

1

A functionalized heterobimetallic (99m)Tc/Re complex as a potential dual-modality imaging probe: synthesis, photophysical properties, cytotoxicity and cellular imaging investigations.

François A, Auzanneau C, Le Morvan V, Galaup C, Godfrey HS, Marty L, Boulay A, Artigau M, Mestre-Voegtlé B, Leygue N, Picard C, Coulais Y, Robert J, Benoist E. François A, et al. Among authors: le morvan v. Dalton Trans. 2014 Jan 14;43(2):439-50. doi: 10.1039/c3dt51968f. Dalton Trans. 2014. PMID: 24061542

2

[Biological bases for individualising prescriptions in oncology: the germline genome].

Robert J, Le Morvan V. Robert J, et al. Among authors: le morvan v. Bull Cancer. 2008 Oct;95(10):911-21. doi: 10.1684/bdc.2008.0722. Bull Cancer. 2008. PMID: 19004720 French.

3

Involvement of gene polymorphisms of thymidylate synthase in gene expression, protein activity and anticancer drug cytotoxicity using the NCI-60 panel.

Nief N, Le Morvan V, Robert J. Nief N, et al. Among authors: le morvan v. Eur J Cancer. 2007 Mar;43(5):955-62. doi: 10.1016/j.ejca.2006.12.012. Epub 2007 Feb 20. Eur J Cancer. 2007. PMID: 17317154

4

Impact of EGFR gene polymorphisms on anticancer drug cytotoxicity in vitro.

Puyo S, Le Morvan V, Robert J. Puyo S, et al. Among authors: le morvan v. Mol Diagn Ther. 2008;12(4):225-34. doi: 10.1007/BF03256288. Mol Diagn Ther. 2008. PMID: 18652519

5

Functional analysis of the gene expression profiles of colorectal cancer cell lines in relation to oxaliplatin and cisplatin cytotoxicity.

Meynard D, Le Morvan V, Bonnet J, Robert J. Meynard D, et al. Among authors: le morvan v. Oncol Rep. 2007 May;17(5):1213-21. Oncol Rep. 2007. PMID: 17390068

6

Deciphering the role of the ERCC2 gene polymorphism on anticancer drug sensitivity.

Moisan F, Laroche-Clary A, Auzanneau C, Ricard N, Pourquier P, Robert J, Le Morvan V. Moisan F, et al. Among authors: le morvan v. Carcinogenesis. 2012 May;33(5):962-8. doi: 10.1093/carcin/bgs107. Epub 2012 Feb 15. Carcinogenesis. 2012. PMID: 22345163

7

Relationships between genetic polymorphisms and anticancer drug cytotoxicity vis-à-vis the NCI-60 panel.

Le Morvan V, Bellott R, Moisan F, Mathoulin-Pélissier S, Bonnet J, Robert J. Le Morvan V, et al. Pharmacogenomics. 2006 Sep;7(6):843-52. doi: 10.2217/14622416.7.6.843. Pharmacogenomics. 2006. PMID: 16981845

8

On the use of pharmacogenetics in cancer treatment and clinical trials.

Robert J, Le Morvan V, Giovannetti E, Peters GJ; PAMM Group of EORTC. Robert J, et al. Among authors: le morvan v. Eur J Cancer. 2014 Oct;50(15):2532-43. doi: 10.1016/j.ejca.2014.07.013. Epub 2014 Aug 4. Eur J Cancer. 2014. PMID: 25103456 Review.

9

Identification of gene polymorphisms of human DNA topoisomerase I in the National Cancer Institute panel of human tumour cell lines.

Moisan F, Longy M, Robert J, Le Morvan V. Moisan F, et al. Among authors: le morvan v. Br J Cancer. 2006 Oct 9;95(7):906-13. doi: 10.1038/sj.bjc.6603361. Epub 2006 Sep 19. Br J Cancer. 2006. PMID: 16983402 Free PMC article.

10

Evaluation of antiproliferative and antioxidant activities of the organic extract and its polar fractions from the Mediterranean gorgonian Eunicella singularis.

Deghrigue M, Dellai A, Akremi N, Le Morvan V, Robert J, Bouraoui A. Deghrigue M, et al. Among authors: le morvan v. Environ Toxicol Pharmacol. 2013 Sep;36(2):339-346. doi: 10.1016/j.etap.2013.04.014. Epub 2013 May 6. Environ Toxicol Pharmacol. 2013. PMID: 23712134

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

37 results

Search Page

Filters